BLENOXANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Blenoxane, and when can generic versions of Blenoxane launch?
Blenoxane is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in BLENOXANE is bleomycin sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Blenoxane
A generic version of BLENOXANE was approved as bleomycin sulfate by HOSPIRA on March 10th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BLENOXANE?
- What are the global sales for BLENOXANE?
- What is Average Wholesale Price for BLENOXANE?
Summary for BLENOXANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Clinical Trials: | 21 |
| Patent Applications: | 3,634 |
| DailyMed Link: | BLENOXANE at DailyMed |
Recent Clinical Trials for BLENOXANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Emmes Company, LLC | Phase 1 |
| University of Arkansas | Phase 1 |
| National Cancer Institute (NCI) | Phase 1 |
US Patents and Regulatory Information for BLENOXANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | BLENOXANE | bleomycin sulfate | INJECTABLE;INJECTION | 050443-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers Squibb | BLENOXANE | bleomycin sulfate | INJECTABLE;INJECTION | 050443-002 | Sep 7, 1995 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
